AKT1 and neoplasm: Greenhough and colleagues reported that induction of CNR1 and CNR2 in colorectal cancer cells inhibits tumorigenic RAS/MAPK and PI3K/AKT signaling [92], while the loss of CNR1 in tumor samples from colon cancer patients correlated with tumor growth [93].